An Extension Study for Participants Who Have Completed the Treatment Period of a Qualifying Parent Study

Condition:   Dermatomyositis Intervention:   Drug: Anti-Beta Interferon (PF-06823859) Sponsor:   Pfizer Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials